Cargando…

Microfluidic Assaying of Circulating Tumor Cells and Its Application in Risk Stratification of Urothelial Bladder Cancer

Bladder cancer is characterized by its frequent recurrence and progression. Effective treatment strategies need to be based on an accurate risk stratification, in which muscle invasiveness and tumor grade represent the two most important factors. Traditional imaging techniques provide preliminary in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Guanghou, Cheng, Kok Suen, Chen, Anqi, Xu, Zhijie, Chen, Xiaoyi, Tian, Junjie, Xu, Congcong, Sun, Yukun, Neoh, Kuang Hong, Dai, Yun, Han, Ray P. S., Jin, Baiye
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222714/ https://www.ncbi.nlm.nih.gov/pubmed/34178700 http://dx.doi.org/10.3389/fonc.2021.701298

Ejemplares similares

Population-based outcome of muscle-invasive bladder cancer following radical cystectomy: who can benefit from adjuvant chemotherapy?
por: Tian, Junjie, et al.
Publicado: (2021)

Microfluidic assay of circulating endothelial cells in coronary artery disease patients with angina pectoris
por: Chen, Shuiyu, et al.
Publicado: (2017)

Activation of cGAS-STING Signal to Inhibit the Proliferation of Bladder Cancer: The Immune Effect of Cisplatin
por: Fu, Guanghou, et al.
Publicado: (2022)

CDCA5 functions as a tumor promoter in bladder cancer by dysregulating mitochondria-mediated apoptosis, cell cycle regulation and PI3k/AKT/mTOR pathway activation
por: Fu, Guanghou, et al.
Publicado: (2020)

RCC1 functions as a tumor facilitator in clear cell renal cell carcinoma by dysregulating cell cycle, apoptosis, and EZH2 stability
por: Wu, Yunfei, et al.
Publicado: (2023)

Management of Primary Female Urethral Adenocarcinoma: Two Rare Case Reports and Literature Review
por: Tian, Junjie, et al.
Publicado: (2023)

Bioinformatics Prediction and Experimental Verification Identify CAB39L as a Diagnostic and Prognostic Biomarker of Kidney Renal Clear Cell Carcinoma
por: Wu, Yunfei, et al.
Publicado: (2023)

POLD1 as a Prognostic Biomarker Correlated with Cell Proliferation and Immune Infiltration in Clear Cell Renal Cell Carcinoma
por: Tian, Junjie, et al.
Publicado: (2023)

SAA1 Has Potential as a Prognostic Biomarker Correlated with Cell Proliferation, Migration, and an Indicator for Immune Infiltration of Tumor Microenvironment in Clear Cell Renal Cell Carcinoma
por: Xu, Zhijie, et al.
Publicado: (2023)

A rare case report of femoral neck metastasis secondary from penile carcinoma and literature review
por: Sun, Junjie, et al.
Publicado: (2021)

CTC phenotyping for a preoperative assessment of tumor metastasis and overall survival of pancreatic ductal adenocarcinoma patients
por: Sun, Yukun, et al.
Publicado: (2019)

Immune Signature-Based Risk Stratification and Prediction of Immunotherapy Efficacy for Bladder Urothelial Carcinoma
por: Liang, Fangfang, et al.
Publicado: (2021)

Identification of Biomarkers Related to M2 Macrophage Infiltration in Alzheimer’s Disease
por: Lin, Caixiu, et al.
Publicado: (2022)

A Novel DNA Methylation Signature as an Independent Prognostic Factor in Muscle-Invasive Bladder Cancer
por: Xu, Zhijie, et al.
Publicado: (2021)

Ameliorative Effect of Daidzein on Cisplatin-Induced Nephrotoxicity in Mice via Modulation of Inflammation, Oxidative Stress, and Cell Death
por: Meng, Hongzhou, et al.
Publicado: (2017)

Integrated proteogenomic characterization of urothelial carcinoma of the bladder
por: Xu, Ning, et al.
Publicado: (2022)

Diagnostic value of HE4+ circulating tumor cells in patients with suspicious ovarian cancer
por: Guo, Yan-Xiu, et al.
Publicado: (2018)

Metachronous urothelial carcinoma of whole urinary tract in a dialysis-dependent patient: A case report
por: WANG, YIMIN, et al.
Publicado: (2016)

Cystic renal cell carcinoma: a report of 67 cases including 4 cases with concurrent renal cell carcinoma
por: Chen, Shanwen, et al.
Publicado: (2014)

Transcriptome sequencing identifies ANLN as a promising prognostic biomarker in bladder urothelial carcinoma
por: Zeng, Shuxiong, et al.
Publicado: (2017)

LINC00941 Promotes Cell Malignant Behavior and Is One of Five Costimulatory Molecule-Related lncRNAs That Predict Prognosis in Renal Clear Cell Carcinoma
por: Pan, Huafeng, et al.
Publicado: (2023)

Lymphocyte antigen 6 superfamily member D is a marker of urothelial and squamous differentiation: implications for risk stratification of bladder cancer
por: Andersson, Nina, et al.
Publicado: (2020)

Intratumoral heterogeneity of surrogate molecular subtypes in urothelial carcinoma in situ of the urinary bladder: implications for prognostic stratification of high-risk non-muscle-invasive bladder cancer
por: Garczyk, Stefan, et al.
Publicado: (2021)

Diagnosis, workup, and risk stratification of upper tract urothelial carcinoma
por: Zganjar, Andrew J., et al.
Publicado: (2023)

Evidence for Bladder Urothelial Pathophysiology in Functional Bladder Disorders
por: Keay, Susan K., et al.
Publicado: (2014)

Review: Application of Nanoparticles in Urothelial Cancer of the Urinary Bladder
por: Chen, Chieh-Hsiao, et al.
Publicado: (2015)

Immune escape mechanisms and immunotherapy of urothelial bladder cancer
por: Yang, Zhao, et al.
Publicado: (2021)

The effect of marital status on the survival of patients with bladder urothelial carcinoma: A SEER database analysis
por: Niu, Quan, et al.
Publicado: (2018)

Risk Stratification for the Rate and Location of Residual Bladder Tumor for the Decision of Re-Transurethral Resection of Bladder Tumor
por: Fan, Junjie, et al.
Publicado: (2022)

Utility of pT3 substaging in lymph node-negative urothelial carcinoma of the bladder: do pathologic parameters add to prognostic sub-stratification?
por: Maas, Moritz, et al.
Publicado: (2021)

Rare presentation of urothelial bladder carcinoma as cardiac tamponade
por: Yeaman, Clinton T., et al.
Publicado: (2017)

Oncogenic Roles of Polycomb Repressive Complex 2 in Bladder Cancer and Upper Tract Urothelial Carcinoma
por: Huang, Eric Yi-Hsiu, et al.
Publicado: (2022)

Differentiating Nonfunctional Paraganglioma of the Bladder from Urothelial Carcinoma of the Bladder: Pitfalls and Breakthroughs
por: Male, Musa, et al.
Publicado: (2019)

Intravesical therapy for urothelial carcinoma of the bladder
por: Manoharan, M.
Publicado: (2011)

Urothelial Bladder Cancer Urinary Biomarkers
por: Noon, Aidan P, et al.
Publicado: (2014)

Role of angiogenesis in urothelial bladder carcinoma
por: Fus, Łukasz Piotr, et al.
Publicado: (2016)

Bladder melanosis with concurrent urothelial carcinoma
por: Yau, Susanna E., et al.
Publicado: (2017)

Cutaneous metastasis of bladder urothelial carcinoma
por: Hasan, Osamah, et al.
Publicado: (2019)

Giant Cell Urothelial Carcinoma of Bladder
por: Wijesinghe, Harshima Disvini, et al.
Publicado: (2021)

Molecular classification of urothelial bladder carcinoma
por: Schwarzova, Lucia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c7046uofgvcq3h41i6hg5a4hmn